This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovations of Jeffrey A. Zimmerman
Introduction
Jeffrey A. Zimmerman is a notable inventor based in Chalfont, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His work has led to the creation of a unique compound that has the potential to impact medical treatments.
Latest Patents
Zimmerman holds a patent for a carbapenem antibiotic. This pharmaceutical composition includes a compound of formula I or a pharmaceutically acceptable salt, prodrug, or hydrate thereof, in a stabilized form and/or in combination with a carbon dioxide source. This innovation represents a crucial advancement in antibiotic development.
Career Highlights
Jeffrey A. Zimmerman is associated with Merck & Co., Inc., a leading global healthcare company. His role at Merck has allowed him to work on groundbreaking research and development projects that aim to improve health outcomes through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Zimmerman has collaborated with esteemed colleagues, including David C. Dubost and Daniel Richard Sidler. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their projects.
Conclusion
Jeffrey A. Zimmerman exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in antibiotic development, highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile